DMW – Klinischer Fortschritt, Table of Contents Dtsch Med Wochenschr 2014; 139(31/32): 1583-1586DOI: 10.1055/s-0034-1370187 Kardiologie | Commentary Kardiologie © Georg Thieme Verlag KG Stuttgart · New York Aortenklappenvitien Aortic valvular disease J.-M. Sinning 1 Medizinische Klinik und Poliklinik II, Herzzentrum der Universität Bonn, Universitätsklinikum Bonn , G. Nickenig 1 Medizinische Klinik und Poliklinik II, Herzzentrum der Universität Bonn, Universitätsklinikum Bonn › Author Affiliations Recommend Article Abstract Buy Article Schlüsselwörter SchlüsselwörterAortenklappeninsuffizienz - Aortenklappenstenose - kathetergestützte Aortenklappenimplantation - TAVI Keywords Keywordsaortic valve regurgitation - aortic valve stenosis - transcatheter aortic valve implantation - TAVI Full Text References Literatur 1 Adams DH, Popma JJ, Reardon MJ et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014; 370: 1790-1798 2 Deutsche Gesellschaft für Kardiologie – Herz-und Kreislaufforschung e.V.. ESC Pocket Guidelines. Herzklappenerkrankung. Grünwald.: Börm Bruckmeier Verlag GmbH; 2014. (Kurzfassung der ESC/EACTS Guidelines on the management of valvular heart disease (version 2012), Eur Heart J 2012; 33: 2451-2496 and Eur J Cardiothorac Surg 2012; 42: S1-S44) 3 Dvir D, Webb J, Brecker S et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation 2012; 126: 2335-2344 4 Eikelboom JW, Connolly SJ, Brueckmann M et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 2013; 369: 1206-1214 5 Grube E, Sinning JM, Vahanian A. The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions). Eur Heart J 2014; 35: 490-495 6 Hamm CW, Möllmann H, Holzhey D. for the GARY-Executive Board et al. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J 2013; (epub ahead of print) 7 Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607 8 Meredith I, Walters D, Dumonteil N et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using the repositionable Lotus Valve System: 30-day primary endpoint results from the 120 Patient REPRISE II Study. Late Breaking Clinical Trial ACC Washington, USA: 2014 9 Schofer J, Colombo A, Klugmann S et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol 2014; 63: 763-768 10 Schueler R, Hammerstingl C, Sinning JM et al. Prognosis of octogenarians with severe aortic valve stenosis at high risk for cardiovascular surgery. Heart 2010; 96: 1831-1836 11 Sedaghat A, Sinning JM, Vasa-Nicotera M et al. The revised EuroSCORE II for the pre-diction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol 2013; 102: 821-829 12 Sinning JM, Hammerstingl C, Vasa-Nicotera M et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol 2012; 59: 1134-1141 13 Smith CR, Leon MB, Mack MJ et al. Transcatheter versus surgical aortic-valve re-placement in high-risk patients. N Engl J Med 2011; 364: 2187-2198 14 Vahanian A, Alfieri O, Andreotti F et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012; 33: 2451-2496
